Pfizer
is expected to report its earnings on Tuesday, a week and a half after an executive told investors the company was looking at a list price for a Covid-19 vaccine between 110 and 130. dollars per adult dose, higher than analysts expected.
The surprise has caused analysts to rethink their estimates of next year’s Covid-19 vaccine sales and raise questions about how they think.
Pfizer
long-term outlook. The company will have the opportunity to solve those problems at the investor call plan at 10 a.m. Tuesday. The company’s third-quarter financial results will be released before the market opens.
